Gorkem Kosehasanogullari
Usak, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Self-injectable DMTs in relapsing MS: NEDA assessment at 10 years in a real-world cohort.
Journal: Acta neurologica Scandinavica
Published: June 19, 2021
Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
Journal: Clinical neurology and neurosurgery
Published: March 20, 2017
Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial.
Journal: Clinical neurology and neurosurgery
Published: February 12, 2017
Monthly Pulse Methylprednisolone Therapy is Effective in Preventing Permanent Disease Progression in Secondary Progressive Multiple Sclerosis.
Journal: Noro psikiyatri arsivi
Published: September 25, 2016
Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: May 02, 2016
Reassessment of Lhermitte's sign in multiple sclerosis.
Journal: Acta neurologica Belgica
Published: September 16, 2014
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
Journal: Clinical neurology and neurosurgery
Published: May 06, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026